XORTX Therapeutics Inc (TSE:XRTX) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
XORTX Therapeutics Inc., a pharmaceutical company specializing in treatments for progressive kidney disease, has received a recommendation from the independent proxy advisory firm ISS for shareholders to vote in favor of all proposed resolutions at the upcoming Annual and Special Meeting. The board of directors supports the ISS’s recommendation, emphasizing the importance of each shareholder’s vote at the meeting scheduled for September 12, 2024.
For further insights into TSE:XRTX stock, check out TipRanks’ Stock Analysis page.
